MX2021015938A - Virus para vacuna contra el síndrome respiratorio y reproductivo porcino. - Google Patents

Virus para vacuna contra el síndrome respiratorio y reproductivo porcino.

Info

Publication number
MX2021015938A
MX2021015938A MX2021015938A MX2021015938A MX2021015938A MX 2021015938 A MX2021015938 A MX 2021015938A MX 2021015938 A MX2021015938 A MX 2021015938A MX 2021015938 A MX2021015938 A MX 2021015938A MX 2021015938 A MX2021015938 A MX 2021015938A
Authority
MX
Mexico
Prior art keywords
viruses
respiratory syndrome
porcine reproductive
modified
vaccine virus
Prior art date
Application number
MX2021015938A
Other languages
English (en)
Inventor
Stephen Qitu Wu
Cinta Prieto Suarez
Geoffrey Gregory Labarque
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of MX2021015938A publication Critical patent/MX2021015938A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a virus del síndrome respiratorio y reproductivo porcino, vivos modificados. Los virus se analizaron genéticamente y se seleccionaron en función de agrupaciones filogenéticas para su modificación mediante pases repetidos en cultivo tisular. Se evaluó la capacidad de los virus vivos modificados para proporcionar inmunidad protectora frente a virus heterólogos. Los virus vivos modificados son útiles en vacunas, particularmente en vacunas que pueden tratar la infección de cerdos por múltiples virus heterólogos.
MX2021015938A 2019-08-29 2019-09-27 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino. MX2021015938A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382734 2019-08-29
PCT/EP2019/076174 WO2021037387A1 (en) 2019-08-29 2019-09-27 Porcine reproductive and respiratory syndrome vaccine virus

Publications (1)

Publication Number Publication Date
MX2021015938A true MX2021015938A (es) 2022-04-26

Family

ID=67902445

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015938A MX2021015938A (es) 2019-08-29 2019-09-27 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino.

Country Status (11)

Country Link
US (1) US20220241393A1 (es)
EP (1) EP4021577A1 (es)
JP (1) JP2022551368A (es)
KR (1) KR20220106679A (es)
CN (1) CN114502240A (es)
AU (1) AU2019463018A1 (es)
BR (1) BR112021026502A2 (es)
CA (1) CA3144160A1 (es)
CL (2) CL2021003447A1 (es)
MX (1) MX2021015938A (es)
WO (1) WO2021037387A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024077281A2 (en) * 2022-10-06 2024-04-11 Cornell University Genotyping and sequencing assays for prrsv

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132106B2 (en) * 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2370372C (en) * 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
PL370541A1 (en) * 2001-03-09 2005-05-30 Boehringer Ingelheim Vetmedica Gmbh Live attenuated strains of prrs virus
EP2558118B1 (en) * 2010-04-16 2019-06-05 Universiteit Gent Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
WO2013017568A1 (en) * 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
ES2940691T3 (es) * 2013-12-20 2023-05-10 Boehringer Ingelheim Vetmedica Gmbh Variante de virus PRRS, clon de ADNc de virus PRRS europeo y usos de los mismos
HUE054877T2 (hu) * 2014-07-21 2021-10-28 Fatro Spa PRRS legyengített törzse és lehetséges alkalmazása immunizáló készítményekben
TWI704225B (zh) * 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
EP3554537A2 (en) * 2016-12-14 2019-10-23 Zoetis Services LLC Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning

Also Published As

Publication number Publication date
JP2022551368A (ja) 2022-12-09
BR112021026502A2 (pt) 2022-03-15
CL2023002187A1 (es) 2023-12-15
EP4021577A1 (en) 2022-07-06
CL2021003447A1 (es) 2022-08-05
AU2019463018A1 (en) 2022-02-03
KR20220106679A (ko) 2022-07-29
US20220241393A1 (en) 2022-08-04
CA3144160A1 (en) 2021-03-04
WO2021037387A1 (en) 2021-03-04
CN114502240A (zh) 2022-05-13

Similar Documents

Publication Publication Date Title
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
TW201613558A (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
MX2013013906A (es) Vacunas combinadas para prevencion de infecciones por virus porcino.
PH12015501378B1 (en) Porcine parvovirus 5a, methods of use and vaccine
MX2019007349A (es) Vacuna combinada para cerdos.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
ME01140B (me) Virus goveđe virusne dijareje s modifikovanim erns proteinom
PH12019501320A1 (en) Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
PH12015501721A1 (en) Porcine parvovirus 5b, methods of use and vaccine
BR112012021650A2 (pt) "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina."
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
MX2022010373A (es) Vacuna contra el virus de la peste porcina africana.
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
EA202191145A1 (ru) Вакцина виб 4/91 с гетерологичным шиповидным белком
MX2014001158A (es) Virus recombinantes de influenza porcina y usos del mismo.
BR112019003181A2 (pt) composição para aumentar uma resposta imune em animal, método para induzir uma resposta imune protetora em um sujeito, e, uso da composição na preparação de um medicamento.
UY38933A (es) Vacuna de partículas tipo virus del chicunguña y métodos para su uso
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
AR109291A1 (es) Clon de adnc del virus del síndrome reproductivo y respiratorio porcino y usos del mismo